Interest in the Use of Dressings With Honey for Wound Healing After Excision of Pilonidal Cyst

Phase 4

Completed

• Conditions: Pilonidal Cysts
• Interventions: Device: Melectis G

• Registration Number: NCT02485860
• Lead Sponsor: Centre Hospitalier Departemental Vendee

Brief Summary

The management of pilonidal cysts is a skin excision and under deep skin. Scarring requires regular dressings (daily for 15 days and then every 48 hours) until complete healing. This healing is obtained on average in 68 days. Some patients have difficulties in healing with a final healing achieved on average in 95 days. Some teams use honey to promote wound cavitary wounds (wound infection, pressure ulcers, varicose wound). The acceleration of wound healing is due to antibacterial properties and hyperosmolarity to reduce secretions. ) The use of honey in pilonidal cysts is not evaluated and may accelerate healing.

Detailed Description

Not available

Study Timeline

• Study First Submitted: 2015-06-26
• Study First Submitted QC: 2015-06-26
• Study First Posted: 2015-06-30
• Study Start: 2016-03-08
• Primary Completion: 2022-02-10
• Study Completion: 2022-02-10
• Status Verified: 2023-01
• Results First Submitted: 2023-01-11
• Results First Submitted QC: 2023-01-11
• Last Update Submitted: 2023-01-11
• Results First Posted: 2023-10-25
• Last Update Posted: 2023-10-25

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 890

Inclusion Criteria

• Cavity Wound to 6 weeks of a pilonidal cyst excision
• Bloodless wound
• Pilonidal cyst not recurred
• Age : 18 years and older
• Signature of informed consent
• In the capacity to understand the study

Exclusion Criteria

• Bleeding wound
• Refused to participate in Protocol
• Patient immunocompromised
• Recurrent pilonidal cyst
• Patients on long-term corticosteroid
• Patient deprived of liberty, under guardianship
• Patient unable to understand the study
• Allergy or hypersensitivity to honey
• Allergy Or hypersensitivity to hyaluronic acid
• Allergy or hypersensitivity to guar gum
• Allergy or hypersensitivity to pectin
• Known allergy to propolis (potentially present in honey)
• Sensitivity to zinc oxide
• Sensitivity known dressings used in this trial or any component
• Diabetes Non-insulin or insulin

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
standard dressings with sterile honey	Melectis G	Melectis G

Primary Outcome Measures

Name	Time	Method
Healing Time	from randomization to 180 days maximum

Trial Locations

Locations (1)

Centre Hospitalier Departemental Vendée; 🇫🇷 La Roche sur Yon, France